Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Melissa R Snyder"'
Autor:
Paula M. Ladwig, Ann L. Rivard, Alex Barbeln, Anthony Maus, David L. Murray, Melissa R. Snyder, Maria A.V. Willrich
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 32, Iss , Pp 24-30 (2024)
Introduction: Therapeutic drug monitoring of infliximab has become the standard of care for inflammatory bowel disease in the setting of loss of response to therapy, and occasionally in proactive therapy personalization. Measurement of infliximab by
Externí odkaz:
https://doaj.org/article/eca8d07ac2a540d78f474e928cb0c67d
Autor:
Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, Michael R. Mueller, Christopher A. Aakre, Elizabeth A. Gilman, Stephanie L. Grach, Joshua Overgaard, Melissa R. Snyder, Nerissa M. Collins, Ivana T. Croghan, Andrew D. Badley, Raymund R. Razonable, Bradley R. Salonen
Publikováno v:
Journal of Primary Care & Community Health, Vol 15 (2024)
Background: Over 30% of patients with COVID-19 have persistent symptoms that last beyond 30 days and referred to as Long COVID. Long COVID has been associated with a persistent elevation in peripheral cytokines including interleukin-6, interleukin-1
Externí odkaz:
https://doaj.org/article/c8b19f3bdac2437dac9b4c228d3ae0b8
Autor:
Maria Alice V. Willrich, David L. Murray, S. Vincent Rajkumar, Sandra C. Bryant, Dirk Larson, Vanessa Pazdernik, Melissa R. Snyder, Robert A. Kyle, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/759dd1a15aa642e69736c1d3ecdd75be
Autor:
Gwen E. Thompson, Lynn A. Fussner, Amber M. Hummel, Darrell R. Schroeder, Francisco Silva, Melissa R. Snyder, Carol A. Langford, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert F. Spiera, E. William St. Clair, John H. Stone, Ulrich Specks
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background: The utility of ANCA testing as an indicator of disease activity in ANCA-associated vasculitis (AAV) remains controversial. This study aimed to determine the association of ANCA testing by various methods and subsequent remission and exami
Externí odkaz:
https://doaj.org/article/5b2b451663a14cfb8d37666f6f1c8cbf
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Antibodies to U1 ribonucleoprotein (U1RNP) were first described more than 50 years ago, and although clinically relevant for antinuclear antibody–associated connective tissue disease (ANA-CTD), test results are challenging to interpret.
Autor:
Surendra Dasari, Mindy C. Kohlhagen, Angela Dispenzieri, Maria A.V. Willrich, Melissa R. Snyder, Taxiarchis V. Kourelis, John A. Lust, John R. Mills, Robert A. Kyle, David L. Murray
Publikováno v:
Mayo Clinic Proceedings. 97:294-307
To verify the analytical performance of a new mass spectrometry-based method, termed MASS-FIX, when screening for plasma cell disorders in a routine clinical laboratory.Results from 19,523 unique patients tested for an M-protein between July 24, 2018
Publikováno v:
The Journal of Applied Laboratory Medicine. 7:75-80
Background Antineutrophil cytoplasmic antibody (ANCA) testing by the indirect immunofluorescence assay (IFA) is important for the diagnosis of autoimmune vasculitis. A common analytical interference for ANCA-IFA is the presence of an antinuclear anti
Autor:
Michael M. Pham, Giovanni Orsolini, Cynthia S. Crowson, Melissa R. Snyder, Rajiv K. Pruthi, Kevin G. Moder
Publikováno v:
Thrombosis and Haemostasis. 122:1948-1950
Autor:
Moritz Binder, Terra L. Lasho, Wazim Mohammed Ismail, Nana A. Ben-Crentsil, Jenna A. Fernandez, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Susan M. Schwager, Jonathan J. Harrington, Melissa R. Snyder, Nathalie M. Droin, Eric Solary, Keith D. Robertson, Eric D. Wieben, Eric Padron, Nicholas Chia, Alexandre Gaspar-Maia, Mrinal M. Patnaik
Publikováno v:
Cancer Research. 83:806-806
Background: COVID-19 causes significant morbidity and mortality, albeit with considerable heterogeneity among affected individuals. It remains unclear which host factors determine disease severity and survival. Given the propensity of clonal hematopo
Autor:
Moritz Binder, Terra L. Lasho, Wazim Mohammed Ismail, Nana A. Ben-Crentsil, Jenna A. Fernandez, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Susan M. Schwager, Jonathan J. Harington, Melissa R. Snyder, Nathalie M. Droin, Eric Solary, Keith D. Robertson, Eric D. Wieben, Eric Padron, Nicholas Chia, Alexandre Gaspar-Maia, Mrinal M. Patnaik
Coronavirus disease 2019 (COVID-19) is associated with significant morbidity and mortality, albeit with considerable heterogeneity among affected individuals. It remains unclear which factors determine severity of illness and long-term outcomes. Emer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ea8e91a2ed17849d0a3de97470e93e1
https://doi.org/10.1101/2022.08.25.505316
https://doi.org/10.1101/2022.08.25.505316